The comparison of clinical outcomes between robotic and open surgery for hilar cholangiocarcinoma (LR301C1)

The comparison of perioperative outcomes between the robotic radical surgery and open surgery for hilar cholangiocarcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024276

Enrollment

Unknown

Registered

2019-07-04

Start date

2019-12-01

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hilar cholangiocarcinoma

Interventions

robotic group:robotic surgery

open group:open surgery

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years, male or female; 2. Pathology: Adenocarcinoma; 3. With the complete follow-up data.

Exclusion criteria

Exclusion criteria: 1. Severe underlying diseases; 2. Conversion to open; 3. A history of neoadjuvant therapy.

Design outcomes

Secondary

Measure	Time frame
operative time;Blood mass;30-day mortality;readmission;length of hospital stay;tumor size;resection margin;the number of harvested lymph nodes;postive lymph nodes;perineural invasion;the depth of infiltration;drainage time;costs;postoperative hospital stay;time to start of oral intake;overall survival;relapse-free survival;refluxing cholangitis;anastomotic stenosis;lymphoceles;	—

Primary

Measure	Time frame
complication rate;biliary fistula;delayed gastric emptying;hepatic dysfunction;intra-abdominal abscess;deep venous thrombosis/pulmonary embolism;other organs failure;	—

Countries

China

Contacts

Public ContactRong Liu

Department of Hepatobiliary and Pancreatic Surgical Oncology, Chinese PLA General Hospital and Chinese PLA Medical School, Nankai university

ljz930815@126.com+86 13520784005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026